{"pmid":32292915,"pmcid":"PMC7142699","title":"The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support.","text":["The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support.","As health systems worldwide grapple with the COVID-19 pandemic, patients on durable LVAD support represent a unique population at risk for the disease. We outline such a patient who developed COVID-19 complicated by \"cytokine storm\" with severe ARDS and myocardial injury; and describe the challenges that arose during management.","JACC Case Rep","Chau, Vinh Q","Oliveros, Estefania","Mahmood, Kiran","Singhvi, Aditi","Lala, Anuradha","Moss, Noah","Gidwani, Umesh","Mancini, Donna M","Pinney, Sean P","Parikh, Aditya","32292915"],"abstract":["As health systems worldwide grapple with the COVID-19 pandemic, patients on durable LVAD support represent a unique population at risk for the disease. We outline such a patient who developed COVID-19 complicated by \"cytokine storm\" with severe ARDS and myocardial injury; and describe the challenges that arose during management."],"journal":"JACC Case Rep","authors":["Chau, Vinh Q","Oliveros, Estefania","Mahmood, Kiran","Singhvi, Aditi","Lala, Anuradha","Moss, Noah","Gidwani, Umesh","Mancini, Donna M","Pinney, Sean P","Parikh, Aditya"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292915","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaccas.2020.04.001","keywords":["ARDS","ARDS, acute respiratory distress syndrome","COVID-19","LVAD","LVAD, left ventricular assist device","MODS, multiorgan dysfunction syndrome","OVID-19, coronavirus disease 2019","PEA, pulseless electrical activity","PI event, pulsatility index event","RV, right ventricle","SARS-CoV-2, severe acute respiratory syndrome coronavirus 2","cytokine storm"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664266295783194624,"score":8.233237,"similar":[{"pmid":32293741,"title":"Analysis of 92 deceased patients with COVID-19.","text":["Analysis of 92 deceased patients with COVID-19.","OBJECTIVE: This retrospective study aimed to analysis the clinical characteristics and complications in death cases with novel coronavirus disease-19 (COVID-19). METHOD: We collected the medical records of 92 patients with COVID-19 in Renmin Hospital of Wuhan University who died during January 6th to February 25th, 2020, summarized the clinical characteristics of complications. RESULTS: There were 91 death cases who developed different complications including acute respiratory distress syndrome (ARDS) (73/91), myocardial injury (31/91), liver injury (15/91), renal insufficiency (14/91), multiple organ dysfunction syndrome (MODS) (14/91) and pneumothorax (1/91). Among these patients, 83 patients had at least one complication. While 1 patient who died of recurrent gastrointestinal bleeding was not directly linked to COVID-19. CONCLUSION: The main complications of deceased patients with COVID-19 were ARDS, myocardial injury, liver injury, renal insufficiency and MODS. This article is protected by copyright. All rights reserved.","J Med Virol","Yang, Fan","Shi, Shaobo","Zhu, Jiling","Shi, Jinzhi","Dai, Kai","Chen, Xiaobei","32293741"],"abstract":["OBJECTIVE: This retrospective study aimed to analysis the clinical characteristics and complications in death cases with novel coronavirus disease-19 (COVID-19). METHOD: We collected the medical records of 92 patients with COVID-19 in Renmin Hospital of Wuhan University who died during January 6th to February 25th, 2020, summarized the clinical characteristics of complications. RESULTS: There were 91 death cases who developed different complications including acute respiratory distress syndrome (ARDS) (73/91), myocardial injury (31/91), liver injury (15/91), renal insufficiency (14/91), multiple organ dysfunction syndrome (MODS) (14/91) and pneumothorax (1/91). Among these patients, 83 patients had at least one complication. While 1 patient who died of recurrent gastrointestinal bleeding was not directly linked to COVID-19. CONCLUSION: The main complications of deceased patients with COVID-19 were ARDS, myocardial injury, liver injury, renal insufficiency and MODS. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yang, Fan","Shi, Shaobo","Zhu, Jiling","Shi, Jinzhi","Dai, Kai","Chen, Xiaobei"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293741","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25891","keywords":["ARDS","COVID-19","Complications","Inflammatory","SARS-CoV-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664266295728668673,"score":144.23044},{"pmid":32283152,"title":"Cytokine Storm in COVID-19 and Treatment.","text":["Cytokine Storm in COVID-19 and Treatment.","Cytokine storm is an excessive immune response to external stimuli. The pathogenesis of the cytokine storm is complex. The disease progresses rapidly, and the mortality is high. Certain evidence shows that, during the coronavirus disease 2019 (COVID-19) epidemic, the severe deterioration of some patients has been closely related to the cytokine storm in their bodies. This article reviews the occurrence mechanism and treatment strategies of the COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment.","J Infect","Ye, Qing","Wang, Bili","Mao, Jianhua","32283152"],"abstract":["Cytokine storm is an excessive immune response to external stimuli. The pathogenesis of the cytokine storm is complex. The disease progresses rapidly, and the mortality is high. Certain evidence shows that, during the coronavirus disease 2019 (COVID-19) epidemic, the severe deterioration of some patients has been closely related to the cytokine storm in their bodies. This article reviews the occurrence mechanism and treatment strategies of the COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment."],"journal":"J Infect","authors":["Ye, Qing","Wang, Bili","Mao, Jianhua"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283152","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jinf.2020.03.037","keywords":["2019-nCoV","Coronavirus","Cytokine storm","Immunomodulation","SARS-CoV-2"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"locations":["Cytokine"],"_version_":1664182200737726464,"score":135.11806},{"pmid":32289115,"pmcid":"PMC7128473","title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.","text":["Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.","The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention.","JHEP Rep","Boettler, Tobias","Newsome, Philip N","Mondelli, Mario U","Maticic, Mojca","Cordero, Elisa","Cornberg, Markus","Berg, Thomas","32289115"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention."],"journal":"JHEP Rep","authors":["Boettler, Tobias","Newsome, Philip N","Mondelli, Mario U","Maticic, Mojca","Cordero, Elisa","Cornberg, Markus","Berg, Thomas"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289115","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jhepr.2020.100113","keywords":["ACE-I, angiotensin-converting enzyme inhibitor","ACE2, angiotensin-converting enzyme 2","ACLF, acute-on-chronic liver failure","ALT, alanine aminotransferase","AST, aspartate aminotransferase","COVID-19, coronavirus disease 2019","EGD, esophagogastroduodenoscopy","ERC, endoscopic retrograde cholangiography","HCC, hepatocellular carcinoma","MELD, model for end-stage liver disease","NAFLD, non-alcoholic fatty liver disease","NASH, non-alcoholic steatohepatitis","NUC, nucleoside analogue","PIs, protease inhibitors","RdRp, RNA-dependent RNA polymerase","SARS-CoV-2, severe acute respiratory syndrome coronavirus 2","ULN, upper limit of normal"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664071627216781312,"score":124.01397},{"pmid":32304393,"title":"Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the time of COVID-19 pandemic.","text":["Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the time of COVID-19 pandemic.","We report on the role of fluorine 18-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) scan examinations to contribute in the diagnosis of COVID-19 respiratory syndrome even in the case of asymptomatic left ventricular assist device (LVAD) recipients. Thus, warm caution and thoughtful approaches for timely detection should be taken for our delicate LVAD population expecially if patients are currently living in a high density COVID-19 infected area and the pontential intention for LVAD treatment is bridge to transplantation.","ASAIO J","Loforte, Antonio","Gliozzi, Gregorio","Martin Suarez, Sofia","Pacini, Davide","32304393"],"abstract":["We report on the role of fluorine 18-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) scan examinations to contribute in the diagnosis of COVID-19 respiratory syndrome even in the case of asymptomatic left ventricular assist device (LVAD) recipients. Thus, warm caution and thoughtful approaches for timely detection should be taken for our delicate LVAD population expecially if patients are currently living in a high density COVID-19 infected area and the pontential intention for LVAD treatment is bridge to transplantation."],"journal":"ASAIO J","authors":["Loforte, Antonio","Gliozzi, Gregorio","Martin Suarez, Sofia","Pacini, Davide"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304393","week":"202016|Apr 13 - Apr 19","doi":"10.1097/MAT.0000000000001176","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664431720530706432,"score":121.84665},{"pmid":32282977,"title":"First case of COVID-19 in a kidney transplant recipient treated with belatacept.","text":["First case of COVID-19 in a kidney transplant recipient treated with belatacept.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1).","Am J Transplant","Marx, David","Moulin, Bruno","Fafi-Kremer, Samira","Benotmane, Ilies","Gautier, Gabriela","Perrin, Peggy","Caillard, Sophie","32282977"],"abstract":["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1)."],"journal":"Am J Transplant","authors":["Marx, David","Moulin, Bruno","Fafi-Kremer, Samira","Benotmane, Ilies","Gautier, Gabriela","Perrin, Peggy","Caillard, Sophie"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282977","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15919","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664182200668520448,"score":117.48952}]}